HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 03-30-2004, 11:55 PM   #1
Paul
Guest
 
Posts: n/a
CP-724 714 an oral HER2 receptor inhibitor was discovered as part of OSI's long-standing cancer discovery program with Pfizer Inc. and is currently in Phase I clinical development by Pfizer. Data presented at the meeting demonstrated that CP-724 714 has significant anti-proliferative activity in human breast cancer cell lines with elevated levels of HER2 (9 of 9 cell lines) whereas cell lines without HER2 amplification demonstrated activity in fewer cell lines (3 of 13 cell lines).

Additional data reported by OSI at the AACR annual meeting suggested that the combination of CP-724 714 and Herceptin(R) provided better anti-tumor efficacy than treatment by either agent alone in a human breast carcinoma xenograft model.

  Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 02:48 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter